Survival, mortality and causes of death in inflammatory myopathies
about
Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis.Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China.Morbidity and mortality in adult polymyositis and dermatomyositis.Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 casesEarly illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.Pulmonary hypertension in parenchymal lung disease.Investigation into the cause of mortality in 49 cases of idiopathic inflammatory myopathy: A single center studyDistribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositisThe Correlation of Muscle Biopsy Scores with the Clinical Variables in Idiopathic Inflammatory Myopathies.Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009.Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.Hypercapnic respiratory failure during pregnancy due to polymyositis-related respiratory muscle weakness: a case report.Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain.Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study.Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India.
P2860
Q33397195-0021EB0F-521F-4B83-B16E-777D37283368Q33649923-D5B12A31-F430-4FEB-A098-DEE87905372CQ33715014-77C54014-C670-48EE-B34F-2188F471C7FBQ34070882-90811E14-E82F-4A32-A056-7C303C5E5DF4Q34260708-A77B269D-0F90-446D-B808-BE1FB5F86072Q34495766-F30C04FF-2D21-4CFF-A0F3-D06931101802Q36283423-57C69BC0-414E-4B09-8369-ADAC2439718FQ36328903-604ECB5B-4863-4B93-91DD-A496958ADC85Q36639876-656DF30D-0B2E-41B3-9B6B-A3F8E6F15B3DQ37080228-E9F8CB5F-902D-4BEA-A8E1-2DDB0EB0B9E5Q37570702-B6545274-66FB-4B8E-9702-CE0C6CF564B3Q37690885-DD797332-AB74-41AC-BD1B-B05BE0C9524CQ37704799-17179EE5-93B3-4AD4-AFFD-223FF0BFF7D1Q37734933-FA9ADA6E-0E7E-40C5-8622-78D2444A6DD5Q39160731-EB3760EC-F23E-43A6-9B54-77DAD81B6938Q39776324-AA3ED3B4-B8E5-4824-ABCD-846A81FAD312Q40046472-D9CEEA90-9B9D-4496-B845-EBF47258FE1DQ40069189-1C4DCB15-DB3E-4A06-9575-3F8284803EC8Q40742414-685B3FE0-24D1-41EE-BB86-440162D10E34Q40795767-829F35EA-A3B6-4245-9DCD-DEB349B13FEFQ47425244-85424950-0E72-4B1D-883C-7C907A4BBFEEQ50654020-17D595FF-4D25-4D24-A6FF-FB44707B1013
P2860
Survival, mortality and causes of death in inflammatory myopathies
description
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2006
@uk
name
Survival, mortality and causes of death in inflammatory myopathies
@en
Survival, mortality and causes of death in inflammatory myopathies
@nl
type
label
Survival, mortality and causes of death in inflammatory myopathies
@en
Survival, mortality and causes of death in inflammatory myopathies
@nl
prefLabel
Survival, mortality and causes of death in inflammatory myopathies
@en
Survival, mortality and causes of death in inflammatory myopathies
@nl
P2093
P2860
P50
P1433
P1476
Survival, mortality and causes of death in inflammatory myopathies
@en
P2093
Ana Cabello
Belén Ramos
Carmen Torres
F. Javier Gómez-Reino
Rebeca Belmonte
P2860
P304
P356
10.1080/08916930600622603
P577
2006-01-01T00:00:00Z